Cargando…

Preparation and Evaluation of [(18)F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [(68)Ga]Ga-DOTA/NOTA-NOC

Background: The somatostatin receptors 1–5 are overexpressed on neuroendocrine neoplasms and, as such, represent a favorable target for molecular imaging. This study investigates the potential of [(18)F]AlF-NOTA-[1-Nal(3)]-Octreotide and compares it in vivo to DOTA- and NOTA-[1-Nal(3)]-Octreotide ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dam, Johan Hygum, Langkjær, Niels, Baun, Christina, Olsen, Birgitte Brinkmann, Nielsen, Aaraby Yoheswaran, Thisgaard, Helge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609173/ https://www.ncbi.nlm.nih.gov/pubmed/36296411 http://dx.doi.org/10.3390/molecules27206818

Ejemplares similares

Initial Clinical Experience with (68)Ga-DOTA-NOC Prepared Using (68)Ga from Nanoceria-polyacrylonitrile Composite Sorbent-based (68)Ge/(68)Ga Generator and Freeze-dried DOTA-NOC Kits
por: Chandra, Piyush, et al.
Publicado: (2017)

Evaluation of (18)F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with (68)Ga-DOTATATE PET/CT
por: Hou, Jiale, et al.
Publicado: (2021)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

Highly variable biodistribution of (68)Ga labeled somatostatin analogues (68)Ga-DOTA-NOC and (68)Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT
por: Cheng, Monica, et al.
Publicado: (2022)

Inflammatory Myofibroblastic Tumor: Findings on (68)Ga-DOTA-NOC Positron-emission Tomography-Computed Tomography
por: Tripathy, Sarthak, et al.
Publicado: (2020)

Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
por: Guo, Ning, et al.
Publicado: (2012)

Al[(18)F]F-NOTA-Octreotide Is Comparable to [(68)Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population
por: Haeger, Arlette, et al.
Publicado: (2023)

Exploring Alternative Radiolabeling Strategies for Sialic Acid-Binding Immunoglobulin-Like Lectin 9 Peptide: [(68)Ga]Ga- and [(18)F]AlF-NOTA-Siglec-9
por: Moisio, Olli, et al.
Publicado: (2018)

Ga-68 DOTA-NOC PET/CT for the Detection of Residual/Recurrence in a Rare Case of Sacral Spinal Canal Paraganglioma
por: Jain, Tarun Kumar, et al.
Publicado: (2016)

Small cell lung cancer mimicking lymphoma in CT and (68)Ga-DOTA-NOC PET/CT: A case report
por: Lu, Liyan, et al.
Publicado: (2018)

Correlation between Standardized Uptake Value of (68)Ga-DOTA-NOC Positron Emission Tomography/Computed Tomography and Pathological Classification of Neuroendocrine Tumors
por: Kaewput, Chalermrat, et al.
Publicado: (2018)

Evaluation of a respiratory motion-corrected image reconstruction algorithm in 2-[(18)F]FDG and [(68)Ga]Ga-DOTA-NOC PET/CT: impacts on image quality and tumor quantification
por: Meng, Qing-Le, et al.
Publicado: (2022)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Phantom and clinical evaluation of the effect of a new Bayesian penalized likelihood reconstruction algorithm (HYPER Iterative) on (68)Ga-DOTA-NOC PET/CT image quality
por: Xu, Lei, et al.
Publicado: (2022)

(68)Ga-NOTA PET imaging for gastric emptying assessment in mice
por: Chen, Xueyan, et al.
Publicado: (2021)

PET Imaging of Hepatocellular Carcinoma Using ZD2-((68)Ga-NOTA)
por: Sergeeva, Olga, et al.
Publicado: (2023)

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
por: Kiesewetter, Dale O., et al.
Publicado: (2012)

Preparation, Optimisation, and In Vitro Evaluation of [(18)F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET
por: Hassan, Hishar, et al.
Publicado: (2022)

Preclinical evaluation of [(58m)Co]Co-DOTA-PSMA-617 for Auger electron therapy of prostate cancer
por: Baun, Christina, et al.
Publicado: (2023)

The Search for an Alternative to [(68)Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of (18)F-labeled Somatostatin Analog Development
por: Waldmann, Christopher M., et al.
Publicado: (2019)

Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [(68)Ga]pentixafor
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

Radiosynthesis and preclinical evaluation of [(68)Ga]Ga-NOTA-folate for PET imaging of folate receptor β-positive macrophages
por: Moisio, Olli, et al.
Publicado: (2020)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

Biological Evaluation of [(18)F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma
por: Lin, Liping, et al.
Publicado: (2021)

Design, Synthesis, and Preliminary Evaluation of [(68)Ga]Ga-NOTA-Insulin as a PET Probe in an Alzheimer’s Disease Mouse Model
por: Taubel, Jillissa C., et al.
Publicado: (2022)

The Noc-Domain Containing C-Terminus of Noc4p Mediates Both Formation of the Noc4p-Nop14p Submodule and Its Incorporation into the SSU Processome
por: Kühn, Holger, et al.
Publicado: (2009)

Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
por: Notni, Johannes, et al.
Publicado: (2012)

Development of a Novel PET Tracer [(18)F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging
por: Liu, Qinghua, et al.
Publicado: (2015)

Preliminary biological evaluation of (18)F-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent
por: Lu, Chunxiong, et al.
Publicado: (2017)

[(18)F]AlF-NOTA-ADH-1: A new PET molecular radiotracer for imaging of N-cadherin-positive tumors
por: Liu, Zhenfeng, et al.
Publicado: (2023)

[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)

Synthesis, Radiolabeling, and Preliminary in vivo Evaluation of [(68)Ga] IPCAT-NOTA as an Imaging Agent for Dopamine Transporter
por: Farn, Shiou-Shiow, et al.
Publicado: (2021)

(68)Ga-Labeling: Laying the Foundation for an Anti-Radiolytic Formulation for NOTA-sdAb PET Tracers
por: Baudhuin, Henri, et al.
Publicado: (2021)

A Very Unusual Pattern of Intraperitoneal and Extraperitoneal Heterotropic Splenic Tissue-Mimicking Metastases Identified on (68)Ga-DOTA-NOC Positron Emission Tomography/Computed Tomography and 99mTc Heat-denatured Erythrocyte Study
por: Usmani, Sharjeel, et al.
Publicado: (2020)

Preliminary evaluation of (18)F-AlF-NOTA-MAL-Cys(40)-Exendin-4 in rodent heart after myocardial ischemia and reperfusion
por: Pan, Xietian, et al.
Publicado: (2019)

Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [(18)F]AlF-NOTA-FAPI-04 PET/CT Imaging
por: Sun, Fangfang, et al.
Publicado: (2023)

Clasificación de Resultados de Enfermería (NOC) /
Publicado: (2005)

Clasificación de Resultados de Enfermería (NOC) /
Publicado: (2009)

Notas sobre notas /
por: Gutiérrez Heras, Joaquín, 1927-
Publicado: (1998)

Pilot study of (68)Ga-DOTA-F(ab′)(2)-trastuzumab in patients with breast cancer
por: Beylergil, Volkan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iq6f3c75qn55cojattivn4tt3t